This change applies to members that have Individual and Family (Exchange Plans)1 and are on diabetes medication.
As of September 1,2022 and thereafter UHC will no longer cover diabetes medications: Invokana® and Invokamet®
Current Medication Coverage:
UHC will cover these medications for patients that are currently have an authorization, until Dec 31,2022.
New covered medications
Effective for DOS 09/01/2022 and thereafter, we’re covering diabetes medications Farxiga® and Xigduo® XR for Individual Exchange plans.²
Members also have access to alternative diabetes medications:
- Xigduo XR
¹For these plans in Louisiana and Texas, we’ll no longer cover Invokana and Invokamet as of Jan. 1, 2023.
²For these plans in Louisiana and Texas, we’ll cover Farxiga and Xigduo XR as of Jan. 1, 2023.
Find this type of information useful? Follow my blog for more prior authorization updates, medication coverage changes, reimbursement policy updates and much more!
Recent Blog Posts: